This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pharmaceutical patents case clarifies first authorisation
Supplementary Protection Certificate appeal dismissed on reference to European case law
Pharmaceutical company Neurim appealed a decision to turn down its application for a Supplementary Protection Certificate.
The higher court dismissed the appeal, and its judgment clarifies the European definition of first authorisation of a medicinal
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.